Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001) Meeting Abstract


Authors: Mansfield, A. S.; Goodrich, A.; Foster, N. R.; Ernani, V.; Forde, P. M.; Villaruz, L. C.; Raghav, K. P. S.; Romesser, P. B.; Garbacz, K.; Cao, L.; Salvatore, M. M.; Roden, A.; Powell, S. F.; Shergill, A.; Munster, P. N.; Schwartz, G. K.; Grotz, T. E.
Abstract Title: Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001)
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680305113
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.TPS8598
Notes: Meeting Abstract: TPS8598 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Bernard Romesser
    195 Romesser